Revenue Summary of Pharmaron Beijing Co., Ltd.

Pharmaron Beijing Co., Ltd.'s latest annual revenue in 2023 was 11.53 Billion CNY , up 11.58% from previous year.
Pharmaron Beijing Co., Ltd.'s latest quarterly revenue in 2024 Q1 was 2.64 Billion CNY , down -10.59% from previous quarter.
Pharmaron Beijing Co., Ltd. reported a annual revenue of 10.26 Billion CNY in annual revenue 2022, up 37.92% from previous year.
Pharmaron Beijing Co., Ltd. reported a annual revenue of 7.44 Billion CNY in annual revenue 2021, up 45.0% from previous year.
Pharmaron Beijing Co., Ltd. reported a quarterly revenue of 2.64 Billion CNY for 2024 Q1, down -10.59% from previous quarter.
Pharmaron Beijing Co., Ltd. reported a quarterly revenue of 2.9 Billion CNY for 2024 Q2, up 9.96% from previous quarter.

Annual Revenue Chart of Pharmaron Beijing Co., Ltd. (2023 - 2014)

Historical Annual Revenue of Pharmaron Beijing Co., Ltd. (2023 - 2014)

Year	Revenue	Revenue Growth
2023	11.53 Billion CNY	11.58%
2022	10.26 Billion CNY	37.92%
2021	7.44 Billion CNY	45.0%
2020	5.13 Billion CNY	36.64%
2019	3.75 Billion CNY	29.2%
2018	2.9 Billion CNY	26.76%
2017	2.29 Billion CNY	40.38%
2016	1.63 Billion CNY	44.87%
2015	1.12 Billion CNY	42.71%
2014	790.44 Million CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q3	3.21 Billion CNY	10.63%
2024 Q1	2.64 Billion CNY	-10.59%
2024 Q2	2.9 Billion CNY	9.96%
2023 FY	11.45 Billion CNY	11.58%
2023 Q3	2.92 Billion CNY	0.14%
2023 Q2	2.91 Billion CNY	7.06%
2023 Q1	2.72 Billion CNY	-4.87%
2023 Q4	2.95 Billion CNY	1.16%
2022 Q1	2.1 Billion CNY	-1.84%
2022 Q3	2.76 Billion CNY	9.34%
2022 Q4	2.86 Billion CNY	3.44%
2022 FY	10.26 Billion CNY	37.92%
2022 Q2	2.53 Billion CNY	20.39%
2021 Q3	2.01 Billion CNY	12.24%
2021 Q4	2.14 Billion CNY	6.26%
2021 Q1	1.48 Billion CNY	-3.76%
2021 FY	7.44 Billion CNY	45.0%
2021 Q2	1.79 Billion CNY	20.6%
2020 Q3	1.39 Billion CNY	12.87%
2020 Q2	1.23 Billion CNY	28.65%
2020 Q1	959.18 Million CNY	-15.17%
2020 FY	5.13 Billion CNY	36.64%
2020 Q4	1.54 Billion CNY	11.12%
2019 Q4	1.13 Billion CNY	14.21%
2019 Q3	989.97 Million CNY	13.37%
2019 Q2	873.19 Million CNY	14.39%
2019 Q1	763.31 Million CNY	-12.53%
2019 FY	3.75 Billion CNY	29.2%
2018 Q4	872.61 Million CNY	14.08%
2018 FY	2.9 Billion CNY	26.76%
2018 Q3	764.93 Million CNY	11.11%
2018 Q2	688.42 Million CNY	18.26%
2018 Q1	582.14 Million CNY	-14.09%
2017 Q4	677.64 Million CNY	0.0%
2017 FY	2.29 Billion CNY	40.38%
2016 FY	1.63 Billion CNY	44.87%
2015 FY	1.12 Billion CNY	42.71%
2014 FY	790.44 Million CNY	0.0%

Peer Revenue Comparison of Pharmaron Beijing Co., Ltd.

Name	Revenue	Revenue Difference
Shenzhen GuoHua Network Security Technology Co., Ltd.	110.04 Million CNY	-10384.46%
NanHua Bio-medicine Co., Ltd	136.79 Million CNY	-8334.767%
Jiangsu Sihuan Bioengineering Co., Ltd	235.41 Million CNY	-4801.046%
Berry Genomics Co.,Ltd	1.15 Billion CNY	-902.069%
Chengzhi Shareholding Co., Ltd.	12.34 Billion CNY	6.567%
Hualan Biological Engineering Inc.	5.34 Billion CNY	-115.992%
Daan Gene Co., Ltd.	1.18 Billion CNY	-877.054%
Shanghai RAAS Blood Products Co., Ltd.	7.96 Billion CNY	-44.878%
Guilin Sanjin Pharmaceutical Co., Ltd.	2.17 Billion CNY	-431.312%
Baolingbao Biology Co.,Ltd.	2.52 Billion CNY	-357.147%
Tibet Cheezheng Tibetan Medicine Co., Ltd.	2.04 Billion CNY	-464.163%
Jilin Jian Yisheng Pharmaceutical Co., Ltd.	853.66 Million CNY	-1251.584%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.	10.31 Billion CNY	-11.821%
Haisco Pharmaceutical Group Co., Ltd.	3.35 Billion CNY	-243.897%
Asymchem Laboratories (Tianjin) Co., Ltd.	7.82 Billion CNY	-47.447%
Lifecome Biochemistry Co.,Ltd.	507 Million CNY	-2175.717%
Tiansheng Pharmaceutical Group Co., Ltd.	579.33 Million CNY	-1891.594%
Guiyang Xintian Pharmaceutical Co.,Ltd.	953.98 Million CNY	-1109.457%
Sailong Pharmaceutical Group Co., Ltd.	310.62 Million CNY	-3614.421%
Hefei Lifeon Pharmaceutical Co., Ltd.	1.88 Billion CNY	-512.923%
Anhui Anke Biotechnology (Group) Co., Ltd.	2.84 Billion CNY	-306.104%
Inner Mongolia Furui Medical Science Co., Ltd.	1.15 Billion CNY	-900.057%
Chongqing Zhifei Biological Products Co., Ltd.	52.67 Billion CNY	78.098%
Xiangxue Pharmaceutical Co.,Ltd.	2.29 Billion CNY	-401.807%
Zhejiang Jolly Pharmaceutical Co.,LTD	1.94 Billion CNY	-493.979%
Staidson (Beijing) BioPharmaceuticals Co., Ltd.	364.17 Million CNY	-3068.252%
Guanhao Biotech Co.,Ltd.	399.81 Million CNY	-2785.86%
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	1.41 Billion CNY	-718.043%
China Resources Boya Bio-pharmaceutical Group Co., Ltd.	2.63 Billion CNY	-338.389%
Porton Pharma Solutions Ltd.	3.66 Billion CNY	-214.608%
Guangdong VTR Bio-Tech Co., Ltd.	796.02 Million CNY	-1349.457%
Jiangxi Fushine Pharmaceutical Co., Ltd.	1.6 Billion CNY	-616.793%
Shandong Sito Bio-technology Co., Ltd.	1.27 Billion CNY	-801.559%
Yantai Zhenghai Biotechnology Co., Ltd.	413.65 Million CNY	-2689.295%
Hunan Jiudian Pharmaceutical Co., Ltd.	2.69 Billion CNY	-328.522%
Chengdu Kanghua Biological Products Co., Ltd.	1.56 Billion CNY	-636.015%
Beijing Scitop Bio-tech Co., Ltd.	299.24 Million CNY	-3755.743%
Hvsen Biotechnology Co., Ltd.	1.01 Billion CNY	-1031.444%
Zhejiang Wecome Pharmaceutical Company Limited	519.62 Million CNY	-2120.464%
Shenzhen Bioeasy Biotechnology Co., Ltd.	254.1 Million CNY	-4440.615%
Yunnan Botanee Bio-Technology Group Co.LTD	5.45 Billion CNY	-111.435%
Hubei Goto Biopharm Co.,Ltd.	566.39 Million CNY	-1937.078%
Hualan Biological Bacterin Inc.	2.41 Billion CNY	-378.67%

Global Stocks Search

Pharmaron Beijing Co., Ltd. (300759.SZ)

Revenue Summary of Pharmaron Beijing Co., Ltd.

Annual Revenue Chart of Pharmaron Beijing Co., Ltd. (2023 - 2014)

Historical Annual Revenue of Pharmaron Beijing Co., Ltd. (2023 - 2014)

Peer Revenue Comparison of Pharmaron Beijing Co., Ltd.